Abstract
Patients with diabetes mellitus, chronic renal disease, or advanced age who are undergoing percutaneous coronary intervention are at an increased risk of bleeding and thrombosis. This article reviews the clinical implications of these conditions and discusses the therapeutic options currently available for these patient groups.
MeSH terms
-
Age Factors
-
Aged
-
Aged, 80 and over
-
Angioplasty, Balloon, Coronary / adverse effects*
-
Anticoagulants / therapeutic use
-
Blood Coagulation
-
Cardiovascular Diseases / blood
-
Cardiovascular Diseases / etiology*
-
Cardiovascular Diseases / prevention & control
-
Diabetes Complications / blood
-
Diabetes Complications / etiology*
-
Diabetes Complications / prevention & control
-
Fibrinolytic Agents / therapeutic use
-
Hemorrhage / blood
-
Hemorrhage / etiology*
-
Hemorrhage / prevention & control
-
Humans
-
Platelet Aggregation Inhibitors / therapeutic use
-
Renal Insufficiency, Chronic / blood
-
Renal Insufficiency, Chronic / complications*
-
Risk Factors
-
Thrombosis / etiology
-
Treatment Outcome
Substances
-
Anticoagulants
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors